Bloomberg Intelligence cover image

Novo Next-Generation Obesity Shot Falls Short of Lilly Rival

Bloomberg Intelligence

00:00

Merck reorganizes around patent cliffs

Sam outlines Merck's split of its pharma unit, the rationale for distinct oncology focus and potential pipeline benefits.

Play episode from 05:10
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app